This week’s Medicare updates include the 2021 Quality Payment Program proposed rule, new FAQs regarding COVID-19 topics, the October update to the clinical laboratory fee schedule, and more!
Facing the unprecedented COVID-19 public health emergency, CMS released the 2021 OPPS proposed rule later than ever before, with the agency generally reinforcing its recent focus on site-neutral payment policies, lowering reimbursement for drugs purchased under the 340B program, and adding more services to the list of prior authorization.
In response to the novel coronavirus (COVID-19) public health emergency, CMS has expanded patient access to telehealth services, allowing beneficiaries to receive a wide range of services without having to visit a healthcare facility.
Judith L. Kares, JD, writes about the unique coverage, billing, and payment rules that apply to these blood products and related services under Part B.
CMS recently issued a major update to frequently asked questions (FAQ) on COVID-19 fee-for-service billing issues. The bulk of the new FAQs concerns hospitals and the ability to invoke various waivers in order to deliver services to patients in their homes using telecommunications technologies.
Learn how revenue cycle professionals have managed the constant change and monitored for potential problem areas brought on by the public health emergency.
